Global Live Cell Encapsulation Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Live Cell Encapsulation Market
Live cell encapsulation has long been proposed as a solution in modern medicine to many therapeutic problems. Cell encapsulation technology is used for the immobilization of cells within biocompatible and semipermeable membranes. The encapsulation of cells, instead of therapeutic products, is used to allow the delivery of molecules of interest for a longer time period as cells release these molecules of interest continuously. Furthermore, cells can be engineered for expressing the protein of interest in vivo without modifying the host's genome. Cell encapsulation presents a significant advantage compared to protein encapsulation, as cell encapsulation allows a sustained and controlled delivery therapeutic molecules at a constant rate, thereby resulting in greater physiological concentrations.

The Live Cell Encapsulation industry can be broken down into several segments, Alginate, HEMA-MMA, etc.

Across the world, the major players cover BioTime, Reed Pacific, Viacyte, etc.

The global Live Cell Encapsulation market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Global Live Cell Encapsulation key players include Viacyte, Inc., Living Cell Technologies Ltd., Sigilon Therapeutics, Inc, Sernova Corporation, PharmaCyte Biotech Inc, Gloriana Therapeutics, Kadimastem, Beta-O2 Technologies, Inc., Altucell, Inc., Diatranz Otsuka Ltd, etc.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Live Cell Encapsulation market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Live Cell Encapsulation market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Live Cell Encapsulation market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Live Cell Encapsulation market.

Impact of Covid-19 Outbreak

This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.

Segmental Analysis

The report has been segmented into product and application segments. The researchers have documented all the products present today in the Live Cell Encapsulation market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.

Live Cell Encapsulation Breakdown Data by Type

Alginate

Chitosan

Cellulose

Others

Live Cell Encapsulation Breakdown Data by Application

Diabetes

Cancer

Epilepsy

Parkinson

Others

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Competitive Landscape

This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:

Viacyte, Inc.

Living Cell Technologies Ltd.

Sigilon Therapeutics, Inc

Sernova Corporation

PharmaCyte Biotech Inc

Gloriana Therapeutics

Kadimastem

Beta-O2 Technologies, Inc.

Altucell, Inc.

Diatranz Otsuka Ltd

TABLE OF CONTENT

1 Report Business Overview
1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Live Cell Encapsulation Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Alginate

1.2.3 Chitosan

1.2.4 Cellulose

1.2.5 Others

1.3 Market by Application

1.3.1 Global Live Cell Encapsulation Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Diabetes

1.3.3 Cancer

1.3.4 Epilepsy

1.3.5 Parkinson

1.3.6 Others

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Live Cell Encapsulation Market Perspective (2017-2028)

2.2 Live Cell Encapsulation Growth Trends by Region

2.2.1 Live Cell Encapsulation Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Live Cell Encapsulation Historic Market Size by Region (2017-2022)

2.2.3 Live Cell Encapsulation Forecasted Market Size by Region (2023-2028)

2.3 Live Cell Encapsulation Market Dynamics

2.3.1 Live Cell Encapsulation Industry Trends

2.3.2 Live Cell Encapsulation Market Drivers

2.3.3 Live Cell Encapsulation Market Challenges

2.3.4 Live Cell Encapsulation Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Live Cell Encapsulation Players by Revenue

3.1.1 Global Top Live Cell Encapsulation Players by Revenue (2017-2022)

3.1.2 Global Live Cell Encapsulation Revenue Market Share by Players (2017-2022)

3.2 Global Live Cell Encapsulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Live Cell Encapsulation Revenue

3.4 Global Live Cell Encapsulation Market Concentration Ratio

3.4.1 Global Live Cell Encapsulation Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Live Cell Encapsulation Revenue in 2021

3.5 Live Cell Encapsulation Key Players Head office and Area Served

3.6 Key Players Live Cell Encapsulation Product Solution and Service

3.7 Date of Enter into Live Cell Encapsulation Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Live Cell Encapsulation Breakdown Data by Type

4.1 Global Live Cell Encapsulation Historic Market Size by Type (2017-2022)

4.2 Global Live Cell Encapsulation Forecasted Market Size by Type (2023-2028)

5 Live Cell Encapsulation Breakdown Data by Application

5.1 Global Live Cell Encapsulation Historic Market Size by Application (2017-2022)

5.2 Global Live Cell Encapsulation Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Live Cell Encapsulation Market Size (2017-2028)

6.2 North America Live Cell Encapsulation Market Size by Type

6.2.1 North America Live Cell Encapsulation Market Size by Type (2017-2022)

6.2.2 North America Live Cell Encapsulation Market Size by Type (2023-2028)

6.2.3 North America Live Cell Encapsulation Market Share by Type (2017-2028)

6.3 North America Live Cell Encapsulation Market Size by Application

6.3.1 North America Live Cell Encapsulation Market Size by Application (2017-2022)

6.3.2 North America Live Cell Encapsulation Market Size by Application (2023-2028)

6.3.3 North America Live Cell Encapsulation Market Share by Application (2017-2028)

6.4 North America Live Cell Encapsulation Market Size by Country

6.4.1 North America Live Cell Encapsulation Market Size by Country (2017-2022)

6.4.2 North America Live Cell Encapsulation Market Size by Country (2023-2028)

6.4.3 United States

6.4.4 Canada

7 Europe

7.1 Europe Live Cell Encapsulation Market Size (2017-2028)

7.2 Europe Live Cell Encapsulation Market Size by Type

7.2.1 Europe Live Cell Encapsulation Market Size by Type (2017-2022)

7.2.2 Europe Live Cell Encapsulation Market Size by Type (2023-2028)

7.2.3 Europe Live Cell Encapsulation Market Share by Type (2017-2028)

7.3 Europe Live Cell Encapsulation Market Size by Application

7.3.1 Europe Live Cell Encapsulation Market Size by Application (2017-2022)

7.3.2 Europe Live Cell Encapsulation Market Size by Application (2023-2028)

7.3.3 Europe Live Cell Encapsulation Market Share by Application (2017-2028)

7.4 Europe Live Cell Encapsulation Market Size by Country

7.4.1 Europe Live Cell Encapsulation Market Size by Country (2017-2022)

7.4.2 Europe Live Cell Encapsulation Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Live Cell Encapsulation Market Size (2017-2028)

8.2 Asia-Pacific Live Cell Encapsulation Market Size by Type

8.2.1 Asia-Pacific Live Cell Encapsulation Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Live Cell Encapsulation Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Live Cell Encapsulation Market Share by Type (2017-2028)

8.3 Asia-Pacific Live Cell Encapsulation Market Size by Application

8.3.1 Asia-Pacific Live Cell Encapsulation Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Live Cell Encapsulation Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Live Cell Encapsulation Market Share by Application (2017-2028)

8.4 Asia-Pacific Live Cell Encapsulation Market Size by Region

8.4.1 Asia-Pacific Live Cell Encapsulation Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Live Cell Encapsulation Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Live Cell Encapsulation Market Size (2017-2028)

9.2 Latin America Live Cell Encapsulation Market Size by Type

9.2.1 Latin America Live Cell Encapsulation Market Size by Type (2017-2022)

9.2.2 Latin America Live Cell Encapsulation Market Size by Type (2023-2028)

9.2.3 Latin America Live Cell Encapsulation Market Share by Type (2017-2028)

9.3 Latin America Live Cell Encapsulation Market Size by Application

9.3.1 Latin America Live Cell Encapsulation Market Size by Application (2017-2022)

9.3.2 Latin America Live Cell Encapsulation Market Size by Application (2023-2028)

9.3.3 Latin America Live Cell Encapsulation Market Share by Application (2017-2028)

9.4 Latin America Live Cell Encapsulation Market Size by Country

9.4.1 Latin America Live Cell Encapsulation Market Size by Country (2017-2022)

9.4.2 Latin America Live Cell Encapsulation Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Live Cell Encapsulation Market Size (2017-2028)

10.2 Middle East & Africa Live Cell Encapsulation Market Size by Type

10.2.1 Middle East & Africa Live Cell Encapsulation Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Live Cell Encapsulation Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Live Cell Encapsulation Market Share by Type (2017-2028)

10.3 Middle East & Africa Live Cell Encapsulation Market Size by Application

10.3.1 Middle East & Africa Live Cell Encapsulation Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Live Cell Encapsulation Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Live Cell Encapsulation Market Share by Application (2017-2028)

10.4 Middle East & Africa Live Cell Encapsulation Market Size by Country

10.4.1 Middle East & Africa Live Cell Encapsulation Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Live Cell Encapsulation Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 Viacyte, Inc.

11.1.1 Viacyte, Inc. Company Details

11.1.2 Viacyte, Inc. Business Overview

11.1.3 Viacyte, Inc. Live Cell Encapsulation Introduction

11.1.4 Viacyte, Inc. Revenue in Live Cell Encapsulation Business (2017-2022)

11.1.5 Viacyte, Inc. Recent Developments

11.2 Living Cell Technologies Ltd.

11.2.1 Living Cell Technologies Ltd. Company Details

11.2.2 Living Cell Technologies Ltd. Business Overview

11.2.3 Living Cell Technologies Ltd. Live Cell Encapsulation Introduction

11.2.4 Living Cell Technologies Ltd. Revenue in Live Cell Encapsulation Business (2017-2022)

11.2.5 Living Cell Technologies Ltd. Recent Developments

11.3 Sigilon Therapeutics, Inc

11.3.1 Sigilon Therapeutics, Inc Company Details

11.3.2 Sigilon Therapeutics, Inc Business Overview

11.3.3 Sigilon Therapeutics, Inc Live Cell Encapsulation Introduction

11.3.4 Sigilon Therapeutics, Inc Revenue in Live Cell Encapsulation Business (2017-2022)

11.3.5 Sigilon Therapeutics, Inc Recent Developments

11.4 Sernova Corporation

11.4.1 Sernova Corporation Company Details

11.4.2 Sernova Corporation Business Overview

11.4.3 Sernova Corporation Live Cell Encapsulation Introduction

11.4.4 Sernova Corporation Revenue in Live Cell Encapsulation Business (2017-2022)

11.4.5 Sernova Corporation Recent Developments

11.5 PharmaCyte Biotech Inc

11.5.1 PharmaCyte Biotech Inc Company Details

11.5.2 PharmaCyte Biotech Inc Business Overview

11.5.3 PharmaCyte Biotech Inc Live Cell Encapsulation Introduction

11.5.4 PharmaCyte Biotech Inc Revenue in Live Cell Encapsulation Business (2017-2022)

11.5.5 PharmaCyte Biotech Inc Recent Developments

11.6 Gloriana Therapeutics

11.6.1 Gloriana Therapeutics Company Details

11.6.2 Gloriana Therapeutics Business Overview

11.6.3 Gloriana Therapeutics Live Cell Encapsulation Introduction

11.6.4 Gloriana Therapeutics Revenue in Live Cell Encapsulation Business (2017-2022)

11.6.5 Gloriana Therapeutics Recent Developments

11.7 Kadimastem

11.7.1 Kadimastem Company Details

11.7.2 Kadimastem Business Overview

11.7.3 Kadimastem Live Cell Encapsulation Introduction

11.7.4 Kadimastem Revenue in Live Cell Encapsulation Business (2017-2022)

11.7.5 Kadimastem Recent Developments

11.8 Beta-O2 Technologies, Inc.

11.8.1 Beta-O2 Technologies, Inc. Company Details

11.8.2 Beta-O2 Technologies, Inc. Business Overview

11.8.3 Beta-O2 Technologies, Inc. Live Cell Encapsulation Introduction

11.8.4 Beta-O2 Technologies, Inc. Revenue in Live Cell Encapsulation Business (2017-2022)

11.8.5 Beta-O2 Technologies, Inc. Recent Developments

11.9 Altucell, Inc.

11.9.1 Altucell, Inc. Company Details

11.9.2 Altucell, Inc. Business Overview

11.9.3 Altucell, Inc. Live Cell Encapsulation Introduction

11.9.4 Altucell, Inc. Revenue in Live Cell Encapsulation Business (2017-2022)

11.9.5 Altucell, Inc. Recent Developments

11.10 Diatranz Otsuka Ltd

11.10.1 Diatranz Otsuka Ltd Company Details

11.10.2 Diatranz Otsuka Ltd Business Overview

11.10.3 Diatranz Otsuka Ltd Live Cell Encapsulation Introduction

11.10.4 Diatranz Otsuka Ltd Revenue in Live Cell Encapsulation Business (2017-2022)

11.10.5 Diatranz Otsuka Ltd Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

Choose License Type

Checkout Inquiry Sample